Showing results (171-180 of 196) with videos related to
Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|May 20, 2024
Deep learning and digital pathology powers prediction of HCC development in steatotic liver diseaseTakuma Nakatsuka, Ryosuke Tateishi, Masaya Sato, et al.Journal of Medical Virology|July 18, 2018
Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.Oncology|March 7, 2021
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor TherapyKei Amioka, Tomokazu Kawaoka, Yutaro Ogawa, et al.Antimicrobial Agents and Chemotherapy|June 14, 2021
Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung CellsRuidong Li, Albert Liclican, Yili Xu, et al.Medicine|October 22, 2021
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumabShigeki Yano, Tomokazu Kawaoka, Yusuke Johira, et al.Oncology|February 12, 2018
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor ThrombosisKenichiro Kodama, Tomokazu Kawaoka, Hiroshi Aikata, et al.International Journal of Cancer|September 2, 2022
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinomaPeiyi Zhang, Atsushi Ono, Yasutoshi Fujii, et al.Science Translational Medicine|December 30, 2021
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infectionMeghan S Vermillion, Eisuke Murakami, Bin Ma, et al.Journal of Gastroenterology|December 24, 2013
Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis CHatsue Fujino, Michio Imamura, Yuko Nagaoki, et al.Hepatology (Baltimore, Md.)|April 22, 2025
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver diseaseNaoto Fujiwara, Yuki Matsushita, Mina Tempaku, et al.Pageof 20